Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaintel Regulatory News (MAI)

Share Price Information for Maintel (MAI)

Share Price is delayed by 15 minutes
Get Live Data
92.50    0.00 (0.00%)
Bid:
85.00
Ask:
100.00
Spread: 15.00 (17.647%)
Market Cap: £17.33m
MAI Live PriceLast checked at - London Stock Exchange

Intraday Maintel Share Chart

Director/PDMR Shareholding

19 May 2009 07:00

RNS Number : 4571S
Maintel Holdings PLC
19 May 2009
Β 

ο»Ώ

Maintel Holdings Plc ("Maintel" or "the Company")

Directors'Β share options

OnΒ 18Β MayΒ 2009Β theΒ directors of the Company approved the adoption of the Maintel Holdings PlcΒ 2009 Option Plan.

On the same date, the directors granted to Eddie Buxton, the Company's Chief Executive Officer:

Β 

1. An option overΒ 53,909Β shares,Β which equates toΒ 0.5% ofΒ the issued share capital of the Company, with an exercise price of Β£1.00. The optionΒ will vest and may be exercised from the first date after 18Β May 2009 that the mid market price of the Company's ordinary shares is Β£1.00.

2. An option over the number of shares (if any) that Mr Buxton acquires in the market during the first year of his employment with the Company, with an exercise price of the higher of (a) the prevailing market price at the time ofΒ purchase by Mr Buxton, and (b) Β£1, up to a maximum ofΒ 107,818Β shares,Β which equates toΒ 1.0% of the issued share capital of the Company. The optionΒ will vest andΒ may be exercisedΒ 12 months after the date of Mr Buxton's purchase(s)Β to the extent that the purchased shares are retained at that date.

3. An option overΒ 107,818Β shares,Β which equates toΒ 1.0% of the issued share capital of the Company, with an exercise price of Β£2.00. This optionΒ will vest andΒ may be exercised after 18 months' continuous employment with the Company or, if earlier,Β from the first date after 18Β May 2009 that the mid market price of theΒ Company'sΒ ordinary shares is Β£2.00.

4. An option overΒ 107,818Β shares,Β which equates to 1.0% of the issued share capital of the Company, with an exercise price of Β£3.00. This optionΒ will vest and may be exercised after 3 years'Β continuous employment with the Company or, if earlier,Β from the first date after 18Β May 2009 that the mid market price of theΒ Company'sΒ ordinary shares is Β£3.00.

In each case, the option expires onΒ 18Β May 2019.

In aggregate, therefore, options have been issued over 2.5% of theΒ currentΒ issued share capital, withΒ a maximum ofΒ a further 1% conditional on Mr Buxton purchasing matching shares in the open market.Β The number of shares under option and the vesting and exercise prices may be adjusted at theΒ discretion of the Remuneration Committee in the event of a variation in the issued share capital of the Company. There are no other options outstanding over shares in the Company.

Mr Buxton currently holds no shares in the Company beneficially, but is interested inΒ 52,251Β shares in his capacity as a trustee of theΒ Maintel Holdings Plc Share Incentive Plan.

Enquiries:

Dale Todd - Finance Director 020 7401 0562

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
RDSBLGDURUBGGCI
Date   Source Headline
25th Jun 20269:25 amRNSHolding(s) in Company
22nd Jun 20267:00 amRNSCompletion of Fundraising
3rd Jun 20267:00 amRNSNotice of AGM
1st Jun 20264:44 pmRNSResult of General Meeting
29th May 20262:03 pmRNSResult of Retail Offer and Update on Timing
13th May 20262:35 pmRNSRetail Offer
13th May 20262:30 pmRNSPlacing and Issue of Convertible Loan Notes
11th Feb 20263:26 pmRNSWithdrawal of Requisition
27th Jan 20267:00 amRNSRequisition of General Meeting
22nd Jan 20267:00 amRNSTrading Update
18th Sep 20257:00 amRNSInterim Results
8th Sep 20257:00 amRNS-RNotice of Investor Presentation
3rd Sep 20257:00 amRNSTrading Update
26th Aug 20257:00 amRNSAppointment of Non-Executive Chair
6th Aug 20257:00 amRNS-RAppointment of Chief Operating Officer
29th Jul 20257:00 amRNSTrading Update and Notice of Results
3rd Jun 20255:32 pmRNSResult of Annual General Meeting
3rd Jun 20257:00 amRNSAGM Trading Update
15th May 20257:00 amRNS-RYellowstone Advisory Private Investor Evening
12th May 20257:00 amRNSGrant of Options
8th May 20254:47 pmRNSAnnual Report and Notice of AGM
6th May 20257:00 amRNS2024 Annual Audited Results
2nd May 20257:00 amRNS-RNotice of Investor Presentation
1st May 20257:00 amRNSNotice of Annual Results
22nd Apr 20257:00 amRNSChange of Registered Office
25th Feb 20257:00 amRNSAppointment of Chief Executive Officer
31st Jan 20257:00 amRNSTrading Update
19th Sep 20247:00 amRNSInterim Results
7th Aug 20247:00 amRNSTrading Update and Notice of Results
3rd Jul 20247:00 amRNSAppointment of Non-Executive Directors
19th Jun 20242:24 pmRNSResult of AGM
19th Jun 20247:00 amRNSAGM Trading Update
10th May 20245:02 pmRNSAnnual Report and Notice of AGM
3rd May 202410:01 amRNSPublication of Annual Report
1st May 20247:00 amRNSFinal Results
18th Apr 202412:30 pmRNSBoard Changes
18th Apr 20247:00 amRNSNotice of Final Results
8th Mar 20247:00 amRNSDirector/PDMR Shareholding
27th Feb 20247:00 amRNSBoard Changes
22nd Jan 20247:00 amRNSTrading Update and Notice of Results
16th Oct 20234:15 pmRNSHolding(s) in Company
5th Oct 20237:00 amRNSDirector/PDMR Shareholding
19th Sep 20231:34 pmRNSReplacement: Interim results
19th Sep 20237:00 amRNSInterim results
4th Aug 20237:00 amRNSDirector/PDMR Shareholding
3rd Aug 20237:00 amRNSTrading update and Notice of Results
30th May 20235:25 pmRNSResults of AGM and Board Changes
30th May 20231:03 pmRNSAGM Statement
11th May 20232:20 pmRNSDirector Appointment
4th May 20235:15 pmRNSPosting of Annual Report and Notice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.